Ligand Pharmaceuticals LGND Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's accounts payable?
- Ligand Pharmaceuticals (LGND) reported accounts payable of $5.26M in Q1 2026.
- How has Ligand Pharmaceuticals's accounts payable changed year-over-year?
- Ligand Pharmaceuticals's accounts payable decreased by 1.9% year-over-year, from $5.37M to $5.26M.
- What is the long-term trend for Ligand Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's accounts payable has grown at a -3.1% compound annual growth rate (CAGR), from $3.78M to $3.24M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.